Nisa Investment Advisors’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$309K Sell
14,410
-175
-1% -$2.68K ﹤0.01% 1106
2026
Q1
$202K Buy
14,585
+3,034
+26% +$48.3K ﹤0.01% 1209
2025
Q4
$188K Sell
11,551
-983
-8% -$16K ﹤0.01% 1247
2025
Q3
$188K Hold
12,534
﹤0.01% 1264
2025
Q2
$146K Sell
12,534
-632
-5% -$5.74K ﹤0.01% 1295
2025
Q1
$97.8K Buy
13,166
+38
+0.3% +$292 ﹤0.01% 1413
2024
Q4
$78.7K Buy
13,128
+44
+0.3% +$243 ﹤0.01% 1539
2024
Q3
$67K Sell
13,084
-308
-2% -$1.34K ﹤0.01% 1558
2024
Q2
$48.5K Buy
13,392
+11,852
+770% +$37.6K ﹤0.01% 1679
2024
Q1
$4.94K Buy
1,540
+120
+8% +$464 ﹤0.01% 2120
2023
Q4
$6.96K Sell
1,420
-106
-7% -$484 ﹤0.01% 2090
2023
Q3
$8.32K Hold
1,526
﹤0.01% 2212
2023
Q2
$10.2K Sell
1,526
-4,400
-74% -$32.7K ﹤0.01% 2253
2023
Q1
$52K Hold
5,926
﹤0.01% 1702
2022
Q4
$45K Hold
5,926
﹤0.01% 1805
2022
Q3
$46K Sell
5,926
-52
-0.9% -$490 ﹤0.01% 1762
2022
Q2
$48K Buy
5,978
+5,820
+3,684% +$51.2K ﹤0.01% 1739
2022
Q1
$2K Hold
158
﹤0.01% 2337
2021
Q4
$3K Sell
158
-217
-58% -$6.65K ﹤0.01% 2108
2021
Q3
$13K Sell
375
-3,041
-89% -$110K ﹤0.01% 2166
2021
Q2
$140K Hold
3,416
﹤0.01% 1547
2021
Q1
$138K Hold
3,416
﹤0.01% 1613
2020
Q4
$202K Buy
+3,416
New +$176K ﹤0.01% 1468

Other funds holding ADPT

Nisa Investment Advisors's ADPT Position: Q2 2026 in Review

Nisa Investment Advisors reduced its Adaptive Biotechnologies (ADPT) stake by 1.2% in Q2 2026, selling an estimated $2.68K and leaving 14,410 shares worth $309K. The position accounts for ﹤0.01% of the portfolio, ranked #1106.

Nisa Investment Advisors first reported a position in ADPT in Q4 2020 and has held it in 23 quarters since. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Nisa Investment Advisors held 14,410 shares of Adaptive Biotechnologies worth $309K as of Q2 2026.
  • Nisa Investment Advisors sold 175 Adaptive Biotechnologies shares in Q2 2026, an estimated $2.68K.
  • Adaptive Biotechnologies made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1106 holding.
  • Nisa Investment Advisors first reported a position in Adaptive Biotechnologies in Q4 2020 and has held it in 23 quarters since.
  • 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.